Related references
Note: Only part of the references are listed.Resveratrol suppresses prostate cancer progression in transgenic mice
Curt E. Harper et al.
CARCINOGENESIS (2007)
Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent
David J. Boocock et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2007)
Non-genomic action of resveratrol on androgen and oestrogen receptors in prostate cancer:: modulation of the phosphoinositide 3-kinase pathway
D. A. Benitez et al.
BRITISH JOURNAL OF CANCER (2007)
17β-estradiol differentially regulates androgen-responsive genes through estrogen receptor-β- and extracellular-signal regulated kinase-dependent pathways in LNCaP human prostate cancer cells
Yoko Takahashi et al.
MOLECULAR CARCINOGENESIS (2007)
Molecular signatures of soy-derived phytochemicals in androgen-responsive prostate cancer cells: A comparison study using DNA microarray
Yoko Takahashi et al.
MOLECULAR CARCINOGENESIS (2006)
Androgens induce prostate cancer cell proliferation through mammalian target of rapamycin activation and post-transcriptional increases in cyclin D proteins
Youyuan Xu et al.
CANCER RESEARCH (2006)
Resveratrol-caused apoptosis of human prostate carcinoma LNCaP cells is mediated via modulation of phosphatidylinositol 3′-kinase/Akt pathway and Bcl-2 family proteins
Moammir H. Aziz et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Genistein affects androgen-responsive genes through both androgen- and estrogen-induced signaling pathways
Y Takahashi et al.
MOLECULAR CARCINOGENESIS (2006)
Therapeutic potential of resveratrol: the in vivo evidence
Joseph A. Baur et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Akt-regulated pathways in prostate cancer
PK Majumder et al.
ONCOGENE (2005)
Resveratrol-induced gene expression profiles in human prostate cancer cells
SB Jones et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2005)
Of mice and men: values and liabilities of the athymic nude mouse model in anticancer drug development
LR Kelland
EUROPEAN JOURNAL OF CANCER (2004)
Resveratrol modulates the phosphoinositide 3-kinase pathway through an estrogen receptor α-dependent mechanism:: Relevance in cell proliferation
E Pozo-Guisado et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Estrogenic effects of resveratrol in breast cancer cells expressing mutant and wild-type estrogen receptors: role of AF-1 and AF-2
BD Gehm et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2004)
Androgen receptor: A key molecule in the progression of prostate cancer to hormone independence
ME Taplin et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2004)
Estrogens and anti-estrogens: Key mediators of prostate carcinogenesis and new therapeutic candidates
SM Ho
JOURNAL OF CELLULAR BIOCHEMISTRY (2004)
Differential expression of genes induced by resveratrol in LNCaP cells: P53-mediated molecular targets
BA Narayanan et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Androgens and prostate cancer
AI So et al.
WORLD JOURNAL OF UROLOGY (2003)
Chemoprevention of prostate cancer: Current status and future directions
R Lieberman
CANCER AND METASTASIS REVIEWS (2002)
The program of androgen-responsive genes in neoplastic prostate epithelium
PS Nelson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Resveratrol induced serine phosphorylation of p53 causes apoptosis in a mutant p53 prostate cancer cell line
HY Lin et al.
JOURNAL OF UROLOGY (2002)
Metabolism and disposition of resveratrol in rats: Extent of absorption, glucuronidation, and enterohepatic recirculation evidenced by a linked-rat model
JF Marier et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Involvement of human PECAM-1 in angiogenesis and in vitro endothelial cell migration
GY Cao et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2002)
The role of the IGF system in cancer: From basic to clinical studies and clinical applications
SJ Moschos et al.
ONCOLOGY (2002)
Biological effects of resveratrol
KPL Bhat et al.
ANTIOXIDANTS & REDOX SIGNALING (2001)
Share Paper
